コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 bliteration of vessels with stabilization of corneal scar.
2 with postinfectious, full-thickness, central corneal scars.
3 source of fibrotic tissue in nontransparent corneal scars.
4 ages, 3 had post-herpetic leukoma, and 5 had corneal scars.
5 t virus that can cause recurrent disease and corneal scarring.
6 active outcome while eliminating or reducing corneal scarring.
7 n, PAI-1R may be a useful agent in combating corneal scarring.
8 ation of vision in patients with significant corneal scarring.
9 ology and for cell-based therapies targeting corneal scarring.
10 anglion and reduced herpetic blepharitis and corneal scarring.
11 action may be an important goal for reducing corneal scarring.
12 ly protected against HSV-1-induced death and corneal scarring.
13 rimary genes involved in the pathobiology of corneal scarring.
14 nse leading to exacerbation of HSV-1-induced corneal scarring.
15 ice are normally refractory to HSV-1-induced corneal scarring.
16 spite the fact that KOS normally produces no corneal scarring.
17 included partial-thickness anterior stromal corneal scars (15 eyes), Descemet membrane ruptures (6 e
18 causes of vision loss were cataract (19.7%), corneal scars (15.7%), refractive error and amblyopia (1
20 eal neovascularization (44%), dry eye (38%), corneal scarring (26%), ectropion (25%), blepharitis (23
21 or keratoconus (8), microbial keratitis (6), corneal scar (6), corneal keloid (3), chemical injury wi
24 s to naive mice, resulted in exacerbation of corneal scarring after HSV-1 challenge (P < 0.0001).
25 dividually to naive mice, and the affects on corneal scarring after HSV-1 challenge were determined.
26 -nine percent of patients with keratitis had corneal scarring and 26% had vision of 20/40 or worse at
33 ial basement membrane dystrophy, superficial corneal scars, and previous radial keratotomy will have
34 lindness and visual impairment, particularly corneal scarring as a result of vitamin A deficiency, co
35 able refractive outcomes in the treatment of corneal scarring associated with Bowman layer irregulari
42 ected mouse strains had significantly higher corneal scarring (CS) than did McKrae-infected mice.
43 in KOS or McKrae, and the relative amount of corneal scarring determined 28 days after challenge.
44 ta support the hypothesis that CTGF promotes corneal scar formation and imply that regulating CTGF sy
48 ls, increased 50% lethal dose, and decreased corneal scarring in ocularly infected mice compared to t
53 herpetic episodes is high, and the resultant corneal scarring may require penetrating keratoplasty fo
55 ficant corneal irregularities and/or central corneal scarring often secondary to long-standing preope
57 ervous system involvement, acral mutilation, corneal scarring or ulceration, liver failure, and metab
58 eal involvement without scarring), moderate (corneal scarring), or severe (corneal scarring with thin
59 cinated C57BL/6 mice resulted in significant corneal scarring (P < 0.0001), despite the fact that C57
60 ccinated BALB/c mice resulted in significant corneal scarring (P = 0.0003), despite the fact that KOS
61 conjunctival corkscrew vessels (P < 0.001), corneal scarring (P = 0.01) and pingueculae under the ag
65 ntibody titers (approximately 1:800-1:1200), corneal scarring (trace) and survival (100%) were simila
69 f gK vaccination to exacerbate HSV-1-induced corneal scarring was not mouse strain or HSV-1 strain sp
73 ng), moderate (corneal scarring), or severe (corneal scarring with thinning or perforation) disease b
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。